Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. [electronic resource]
- Cancer research Jun 2000
- 2949-54 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0008-5472
Antineoplastic Agents, Phytogenic--pharmacology Apoptosis Bone Neoplasms--secondary Breast Neoplasms--drug therapy Cell Adhesion Cell Cycle--drug effects Cell Movement Clodronic Acid--pharmacology Collagen--metabolism Diphosphonates--pharmacology Dose-Response Relationship, Drug Drug Combinations Flow Cytometry Fluorometry Humans Ibandronic Acid Imidazoles--pharmacology Laminin--metabolism Male Matrix Metalloproteinases--metabolism Neoplasm Invasiveness Neoplasm Metastasis Paclitaxel--pharmacology Prostatic Neoplasms--drug therapy Proteoglycans--metabolism Pyridines--pharmacology Pyridinium Compounds--pharmacology Tumor Cells, Cultured Zinc--metabolism Zoledronic Acid